| Detected | Trial | Change |
|---|---|---|
| 2026-06-12 | NCT06749457 A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and… |
date change Primary completion pushed: 2026-11-30 -> 2027-04-02 |
| 2026-06-12 | NCT06749457 A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and… |
date change Completion pushed: 2027-09-09 -> 2028-01-07 |
| 2026-06-12 | NCT06921785 Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without… |
Trial sites expanded: 217 -> 220 locations |
| 2026-06-12 | NCT07391657 A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA)… |
Trial sites expanded: 111 -> 116 locations |
| 2026-06-12 | NCT05647122 First in Human Study of AZD9592 in Solid Tumors |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-06-12 | NCT05647122 First in Human Study of AZD9592 in Solid Tumors |
Enrollment reduced: 403 -> 167 participants |
| 2026-06-12 | NCT05647122 First in Human Study of AZD9592 in Solid Tumors |
Trial sites reduced: 51 -> 46 locations |
| 2026-06-12 | NCT07052578 Aggressive Disease Treatment Patterns and CtDNA HRR evaluatiON in High-volume metastatiC… |
Trial sites expanded: 18 -> 22 locations |
| 2026-06-12 | NCT07052578 Aggressive Disease Treatment Patterns and CtDNA HRR evaluatiON in High-volume metastatiC… |
date change Primary completion pushed: 2028-06-30 -> 2028-11-30 |
| 2026-06-12 | NCT07052578 Aggressive Disease Treatment Patterns and CtDNA HRR evaluatiON in High-volume metastatiC… |
date change Completion pushed: 2028-06-30 -> 2028-11-30 |
| 2026-06-12 | NCT07446738 A Study to Investigate the Clinical Outcome and Quality of Life in Chinese Post-operative… |
date change Primary completion pushed: 2027-08-30 -> 2027-10-21 |
| 2026-06-12 | NCT07446738 A Study to Investigate the Clinical Outcome and Quality of Life in Chinese Post-operative… |
date change Completion pushed: 2027-08-30 -> 2027-10-21 |
| 2026-06-11 | NCT07608354 A Study to Evaluate the Efficacy and Safety of Concomitant Use of Eplontersen and… |
Primary endpoint(s) modified |
| 2026-06-11 | NCT06706817 A Study to Investigate Changes in Symptoms in Adult Participants With Chronic… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-06-11 | NCT06706817 A Study to Investigate Changes in Symptoms in Adult Participants With Chronic… |
Trial sites reduced: 45 -> 41 locations |
| 2026-06-11 | NCT07455825 A Study to Investigate the Pharmacokinetics of Different Formulations and Safety of… |
Trial completed |
| 2026-06-11 | NCT07044336 Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial… |
Enrollment increased: 700 -> 800 participants |
| 2026-06-11 | NCT07044336 Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial… |
Trial sites expanded: 314 -> 317 locations |
| 2026-06-11 | NCT07044336 Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial… |
date change Primary completion moved earlier: 2028-01-20 -> 2027-10-15 |
| 2026-06-10 | NCT06097728 MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural… |
overall status: "Recruiting" → "Active Not Recruiting" |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-08 | NCT07633158 Prospective, Non-interventional Single-arm Study With Tezepelumab to Investigate the… | Not Yet Recruiting | |
| 2026-06-05 | NCT07630714 A Study to Investigate Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous… | Phase 2 | Not Yet Recruiting |
| 2026-06-03 | NCT07622433 A Phase I, Cross-over Study Comparing the Relative Bioavailability of Laroprovstat Plus… | Phase 1 | Not Yet Recruiting |
| 2026-06-03 | NCT07624305 A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With… | Phase 3 | Not Yet Recruiting |
| 2026-06-03 | NCT07624318 Trop2 NMR Concordance Study | Not Yet Recruiting | |
| 2026-06-01 | NCT07617636 Observational Study That Will Analyse the Spread and Stratification of Lung Cancer Risk… | Not Yet Recruiting | |
| 2026-06-01 | NCT07619118 A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With… | Phase 3 | Not Yet Recruiting |
| 2026-06-01 | NCT07619131 A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With… | Phase 3 | Not Yet Recruiting |
| 2026-05-29 | NCT07612813 A Study to Evaluate the Safety and Pharmacokinetics of AZD7760 in Healthy Japanese Adults | Phase 1 | Not Yet Recruiting |
| 2026-05-29 | NCT07613424 A Study of MET Concordance and Gene Profiling in 1L NSCLC (Genomet) | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07306949 | Real-Life Clinical Efficacy of Acoramidis in Participants With ATTR-CM and Association… | Transthyretin-type Cardiac Amyloidosis | Recruiting |
| NCT07221838 | A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia… | Generalized Myasthenia Gravis | Recruiting |
| NCT06531798 | Post-marketing Phase 4 Safety & Tolerability Study of Breztri aerosphereTM in Indian… | Moderate to Severe COPD | Recruiting |
| NCT07308574 | Post-Marketing Clinical Study of Ravulizumab in Participants With Clinical aHUS | aHUS | Recruiting |
| NCT06594068 | Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in… | Systemic Lupus Erythematosus | Recruiting |
| NCT06651970 | Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL… | Chronic Lymphocytic Leukaemia | Recruiting |
| NCT07279935 | Osimertinib Combined With Chemotherapy in Patients Who Had Distant Recurrence After… | Non-small Cell Lung Cancer | Recruiting |
| NCT07073950 | A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate… | Chronic Obstructive Pulmonary Disease | Recruiting |
| NCT07357597 | An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd)… | Stomatitis | Not Yet Recruiting |
| NCT06610526 | A Study of Dapagliflozin in Chinese Adult Patients With Chronic Kidney Disease | Chronic Kidney Disease | Active, Not Recruiting |
| NCT06422689 | Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on… | Asthma | Active, Not Recruiting |
| NCT05457257 | Clinical Study to Assess the Efficacy and Safety of Olaparib in Chinese Patients With… | Metastatic Castration-resistant Prostate Cancer | Active, Not Recruiting |
| NCT03953300 | Benralizumab Airway Remodeling Study in Severe Eosinophilic Asthmatics | Asthma | Active, Not Recruiting |
| Phase 3 | |||
| NCT07218809 | AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low… | Epithelial Ovarian Cancer | Recruiting |
| NCT07024563 | Study of Ravulizumab in Pediatric Participants With Primary IgAN | IgAN | Recruiting |
| NCT07221253 | A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of… | Biliary Tract Cancer | Recruiting |
| NCT06607627 | PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+… | Generalized Myasthenia Gravis | Recruiting |
| NCT06291376 | Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN) | Immunoglobulin A Nephropathy | Recruiting |
| NCT07007793 | A Study to Assess Efficacy and Safety of Baxdrostat in Participants With Primary… | Primary Hyperaldosteronism | Recruiting |
| NCT06307652 | Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure… | Heart Failure and Impaired Kidney Function | Recruiting |
| NCT06830798 | Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy… | Delayed Graft Function | Recruiting |
| NCT06103864 | A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's… | Breast Cancer | Recruiting |
| NCT06350097 | Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab… | Non-small Cell Lung Cancer | Recruiting |
| NCT06989112 | DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or… | Endometrial Cancer | Recruiting |
| NCT06878261 | A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With… | Chronic Obstructive Pulmonary Disease (COPD) | Recruiting |